Clearside Biomedical, Inc. (CLSD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.3100 |
| Open | 1.3000 |
| Bid | 1.2700 x 100 |
| Ask | 1.3300 x 100 |
| Day's range | 1.3000 - 1.3400 |
| 52-week range | 0.6500 - 2.1200 |
| Volume | |
| Avg. volume | 375,679 |
| Market cap | 97.898M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5500 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.33 |
- Thomson Reuters StreetEvents
Q1 2024 Clearside Biomedical Inc Earnings Call
Q1 2024 Clearside Biomedical Inc Earnings Call
Insider MonkeyClearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript May 9, 2024 Clearside Biomedical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Clearside Biomedical First Quarter 2024 Financial Results and Corporate Update Conference Call. […]
ZacksClearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of -21.43% and 76.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.